⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL302252 | 0.82 | — | — | |
| SCHEMBL411469 | 0.80 | — | — | |
| SCHEMBL464927 | 0.71 | — | — | |
| SCHEMBL15238115 | 0.71 | — | — | |
| SCHEMBL11853640 | 0.67 | CRBN (0.39) | — | |
| SCHEMBL535025 | 0.61 | — | — | |
| SCHEMBL5856948 | 0.61 | — | — | |
| SCHEMBL964388 | 0.59 | — | — | |
| SCHEMBL971634 | 0.59 | — | — | |
| SCHEMBL10305 | 0.57 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 8326 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4399206-A1 | PAPD5 AND/OR PAPD7 INHIBITING 4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID DERIVATIVES | Redona Therapeutics, Inc. (US) | 2024-07-17 | — | — | EP | claimed |
| EP-4400504-A1 | THIOPHENE RING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences (CN) | 2024-07-17 | — | — | EP | claimed |
| EP-4389738-A1 | SOS1 INHIBITOR AND USE THEREOF | Kanaph Therapeutics Inc. (KR) | 2024-06-26 | — | — | EP | claimed |
| US-20240199621-A1 | MAP4K4 INHIBITORS | IMPERIAL COLLEGE INNOVATIONS LTD (GB) | 2024-06-20 | — | — | US | claimed |
| CN-118119600-A | SOS1 inhibitors and uses thereof | 治纳辅医药科技有限公司 | 2024-05-31 | — | — | CN | claimed |
| CN-118076602-A | Heteroaryl-acetylenes, pharmaceutical compositions thereof and their therapeutic uses | 嘉兴优博生物技术有限公司 | 2024-05-24 | — | — | CN | claimed |
| EP-3468953-B1 | SUBSTITUTED PYRIDINES AS INHIBITORS OF DNMT1 | GLAXOSMITHKLINE IP DEV LTD (GB) | 2024-05-22 | — | — | EP | claimed |
| WO-2024101336-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 国立大学法人京都大学 | 2024-05-16 | — | — | WO | claimed |
| US-20240140986-A1 | SYNTHETIC URSOLIC ACID DERIVATIVES AND METHODS OF USE THEREOF | REATA PHARMACEUTICALS, INC. | 2024-05-02 | — | — | US | claimed |
| US-20240140919-A1 | MODULATORS OF EUKARYOTIC INITIATION FACTOR 2 | DENALI THERAPEUTICS INC. | 2024-05-02 | — | — | US | claimed |
| US-4616002-A | HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1986-10-07 | — | — | US | claimed |
| US-4587047-A | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines | E. R. SQUIBB & SONS, INC. (US) | 1986-05-06 | — | — | US | claimed |
| EP-0175363-A2 | 4,5-Dihydro-3(2H)-pyridazinones, process for their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1986-03-26 | — | — | EP | claimed |
| EP-0145956-A1 | Composés amidés | CIBA-GEIGY AG (CH) | 1985-06-26 | — | — | EP | claimed |
| EP-0128536-A1 | Fluoromethylthiooxacephalosporin derivatives | SHIONOGI & CO., LTD. (JP) | 1984-12-19 | — | — | EP | claimed |
| EP-0085291-A1 | 2-Oxo-1-(aminocarbonylaminosulfonylaminocarbonyl)azetidines | E.R. Squibb & Sons, Inc. (US) | 1983-08-10 | — | — | EP | claimed |
| US-4386089-A | BACTERICIDES, GROWTH PROMOTERS | BAYER AKTIENGESELLSCHAFT (DE) | 1983-05-31 | — | — | US | claimed |
| EP-0004956-B1 | BETA-LACTAM ANTIBIOTICS, PROCESS FOR THEIR PREPARATION, FODDER ADDITIVES, DRUGS AND PROCESS FOR THEIR PREPARATION | BAYER AG (DE) | 1981-10-14 | — | — | EP | claimed |
| US-4273772-A | Method of reducing gastric secretion | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1981-06-16 | — | — | US | claimed |
| US-4198503-A | 3-Carbamoyl substituted-7-ureido substituted cephalosporins | BEECHAM GROUP LIMITED (GB) | 1980-04-15 | — | — | US | claimed |